Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.09
Delayed Data
As of Apr 17
 -0.205 / -1.54%
Today’s Change
4.13
Today|||52-Week Range
13.42
+15.80%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 13.00. The median estimate represents a -0.65% decrease from the last price of 13.09.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$14.0M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -225.00%
 
 
 
 
 
 
Growthannually -24.17%
 
 
 
 
 
 

Sales

Growthquarterly -58.77%
 
 
 
 
 
 
Growthannually -21.65%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account